Healthcare Triangle, Inc. (HCTI) Analysis

(Bloomberg) -- Shares of tiny Healthcare Triangle Inc. stood out as the most actively-traded name on US exchanges on Thursday, another example of how investor exuberance is fueling wild gyrations throughout the equity market. Most Read from BloombergTrump Awards $1.26 Billion Contract to Build Biggest Immigrant Detention Center in USThe High Costs of Trump’s ‘Big Beautiful’ New Car Loan DeductionCan This Bridge Ease the Troubled US-Canadian Relationship?Salt Lake City Turns Winter Olympic Bid In

**$PALI – Palisade Bio, Inc.** Palisade Bio Inc.'s main product is the PALI-2108 which is a new oral medication designed to treat swelling, irritation, and soreness in the intestins, while specifically targeting ulcerative colitis and fibrostenotic Crohn’s disease. Currently, $PALI is still in Phase 1b of their clinical trial, meaning they have completed Phase 1a with super positive results, showing strong safety and effectiveness. As of April 9, 2025 they commenced dosing for patients in the P...

It is showing movement.. but as someone working in this industry, I like this stock and I think it has value. Back in the days, I should have bought NVIDIA as an avid gamer. I didn’t buy NVDA cheaper and I regret very much now. I don’t want to do that mistake again with $HCTI. I would like to stick with this one and I am following the company closely on LinkedIn and also their news releases. They are now in the AI transformation process and Healthcare (EMR/EHR) is one area which will benefit a...